The human Ah receptor: Hints from dioxin toxicities to deregulated target genes and physiological functions

Biological Chemistry

Volumn 394, Issue 6, 2013, Pages 729-739

  Bock, Karl Walter ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Ah receptor target genes; Cell cycle progression; Cell differentiation; Dioxin mediated toxicities; Human Ah receptor

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; CYTOCHROME P450 1A1; DIOXIN; KYNURENINE;

CANCER GROWTH; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CHEMICAL CARCINOGENESIS; CHLORACNE; DENDRITIC CELL; ENTERITIS; ENVIRONMENTAL EXPOSURE; GENE CONTROL; GENE TARGETING; HUMAN; KERATINOCYTE; MELANOCYTE; MICROARRAY ANALYSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; XENOBIOTIC METABOLISM;

DISEASE; GENE EXPRESSION REGULATION; HUMANS; RECEPTORS, ARYL HYDROCARBON; SIGNAL TRANSDUCTION; TETRACHLORODIBENZODIOXIN;

EID: 84879555576     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/hsz-2012-0340     Document Type: Review

References (100)

1. Alam, M.S., Maekawa, Y., Kitamura, A., Tanigaki, K., Yoshimoto, T., Kishihara, K., and Yasutomo, K. (2010). Notch signaling drives IL-22 secretion in CD4 + T cells by stimulating the aryl hydrocarbon receptor. Proc. Natl. Acad. Sci. USA 107, 5943-5948.
2. Andersson, E.R., Sandberg, R., and Lehndahl, U. (2011). Notch signaling: simplicity in design, versatility in function. Development 138, 3593-3612.
3. Barnes-Ellerbe, S., Knutsen, K.E., and Puga, A. (2004). 2,3,7,8-Tetrachlorodibenzo- p -dioxin blocks androgendependent cell proliferation of LNCaP cells through modulation of pRB phosphorylation. Mol. Pharmacol. 66, 502-511. (Pubitemid 39329248)
4. Barouki, R., Coumoul, X., and Fernandez-Salguero, P. (2007). The aryl hydrocarbon receptor, more than a xenobiotic-interacting protein. FEBS Lett. 581, 3608-3615. (Pubitemid 47080995)
5. Beischlag, T.V., Morales, J.L., Hollingshead, B.D., and Perdew, G.H. (2008). The aryl hydrocarbon receptor complex and the control of gene expression. Crit Rev. Eukaryot. Gene Expr. 18, 207-250. (Pubitemid 351620286)
6. Bergander, L., Wincent, E., Rannug, A., Foroozesh, M., Alworth, W., and Rannug, U. (2004). Metabolic fate of the Ah receptor ligand 6-formylindolo[3,2- b]carbazole. Chem. Biol. Interact. 149, 151-164. (Pubitemid 39402931)
7. Bergander, L.V., Cai, W., Klocke, B., Seifert, M., and Pongratz, I. (2012). Tryptamine serves as a proligand of the AhR transcriptional pathway whose activation is dependent of monoamine oxidases. Mol. Endocrinol. 26, 1542-1551.
8. Biotano, A.E., Wang, J., Romeo, R., Bouchez, L.C., Parker, A.E., Sutton, S.E., Walker, J.R., Flaveny, C.A., Perdew, G.H., Denison, M.S., et al. (2010). Aryl hydrocarbon receptor agonists promote the expansion of human hematopoietic stem cells. Science 329, 1345-1348.
9. Brembilla, N.C., Ramirez, J.M., Chicheportiche, R., Sorg, O., Saurat, J.H., and Chizzolini, C. (2011). In vivo dioxin favors interleukin-22 production by human CD4 + T cells in an aryl hydrocarbon receptor(AhR)-dependent manner. PloS One 6, e18741.
10. Bui, L.C., Tomkiewicz, C., Chevallier, A., Pierre, S., Bats, A.S., Mota, S., Raingeaud, J., Pierre, J., Diry, M., Transy, C., et al. (2009). Nedd9/Hef1/Cas-L mediates the effects of environmental pollutants on cell migration and plasticity. Oncogene 28, 3642-3651.
11. Bunger, M.K., Glover, E., Moran, S.M., Walisser, J.A., Lahvis, G.P., Hsu, E.L., and Bradfield, C.A. (2008). Abnormal liver development and resistance to 2,3,7,8-tetrachloro- p -dioxin toxicity in mice carrying a mutation in the DNA-binding domain of the aryl hydrocarbon receptor. Toxicol. Sci. 106, 83-92.
12. Celso, C.L., Berta, M.A., Braun, K.M., Frye, M., Lyle, S., Zouboulis C.C., and Watt, F.M. (2008). Characterization of bipotential epidermal progenitors derived from human sebaceous gland: Contrasting roles of c-myc and α -catenin. Stem Cells 26; 1241-1252.
13. Consonni, D., Pesatori, A.C., Zocchetti, C., Sindaco, R., D'Oro, L.C., Rubagotti, M., and Bertazzi, P.A. (2008). Mortality in a population exposed to dioxin after the Seveso, Italy, accident in 1976:25 years of follow up. Am. J. Epidemiol. 167, 847-858. (Pubitemid 351451742)
14. Denison, M.S., Soshilov, A.A., He, G., DeGroot, D.E., and Zhao, B. (2011). Exactly the same but different: Promiscuity and diversity in the molecular mechanisms of action of the aryl hydrocarbon (dioxin) receptor. Toxicol. Sci. 124, 1-22.
15. Dietrich, C. and Kaina, B. (2010). The aryl hydrocarbon receptor (AhR) in the regulation of cell-cell contact and tumor growth. Carcinogenesis 31, 1319-1328.
16. Dietrich, C., Faust, D., Budt, S., Moskwa, M., Kunz, A., Bock, K.W., and Oesch, F. (2002). 2,3,7,8-Tetrachlorodibenzo- p -dioxindependent release from contact inhibition in WB-F344 cells: Involvement of cyclin A. Toxicol. Appl. Pharmacol. 183, 117-126. (Pubitemid 35286140)
17. DiNatale, B.C., Murray, I.A., Schroeder, J.C., Flaveny, C.A., Lahoti, T.S., Laurenzana, E.M., Omiecinski, C.J., and Perdew, G.H. (2010). Kynurenic acid is a potent endogenous aryl hydrocarbon receptor ligand that synergistically induces interleukin-6 in the presence of inflammatory signaling. Toxicol. Sci. 115, 89-97.
18. Diry, M., Tomkiewicz, C., Koehle, C., Coumoul, X., Bock, K.W., Barouki, R., and Transy, C. (2006). Activation of the dioxin/aryl hydrocarbon receptor (AhR) modulates cell plasticity through a JNK-dependent mechanism. Oncogene 25, 5570-5574. (Pubitemid 44344107)
19. Enan, E. and Matsumura, F. (1996). Identification of c-Src as the integral component of the cytosolic Ah receptor complex, transducing the signal of 2,3,7,8-tetrachlorodibenzo- p -dioxin (TCDD) through the protein phosphorylation pathway. Biochem. Pharmacol. 52, 1599-1612. (Pubitemid 26375466)
20. Esser, C., Rannug, A. and Stockinger, B. (2009). The aryl hydrocarbon receptor in immunity. Trends Immunol. 30, 447-454.
21. Fan, Y., Boivin, G.P., Knudsen, E.S., Nebert, D.W., Xia, Y., and Puga, A. (2010). The aryl hydrocarbon receptor functions as a tumor suppressor in liver carcinogenesis. Cancer Res. 70, 212-220.
22. Fritsche, E., Schäfer, C., Calles, C., Bernsmann, T., Bernshausen, T., Wurm, M., Huebenthal, U., Cline, J.E., Hajimiragha, H. Schroeder, P., et al. (2007). Lightening up the UV response by identification of the arylhydrocarbon receptor as a cytoplasmatic target for ultraviolet B radiation. Proc. Natl. Acad. Sci. USA 104, 8851-8856. (Pubitemid 47175400)
23. Frueh, F.W., Hayashibara, K.C., Brown, P.O., and Whitlock, J.P. (2001). Use of cDNA microarrays to analyze dioxin-induced changes in human liver gene expression. Toxicol. Lett. 122, 189-203. (Pubitemid 32727282)
24. Gohl, G., Lehmköster, T., Mü nzel, P.A., Schrenk, D., Viehbahn, R., and Bock, K.W. (1996). TCDD-inducible plasminogen activator inhibitor type 2 (PAI-2) in human hepatocytes, HepG2 and monocytic U937 cells. Carcinogenesis 17, 443-449.
25. Hall, J.M., Barhoover, M.A., Kazmin, D., McDonnell, D.P., Greenlee, W.F., and Thomas, R.S. (2010). Activation of the aryl-hydrocarbon receptor inhibits invasive and metastatic features of human breast cancer cells and promotes breast cancer cell differentiation. Mol. Endocrinol. 24, 359-369.
26. Hankinson, O. (1995). The aryl hydrocarbon receptor complex. Ann. Rev. Pharmacol. Toxicol. 35, 307-340.
27. Hebert, C.D., Cao, Q.L., and Birnbaum, L.S. (1990). Inhibition of high-density growth arrest in human squamous carcinoma cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Carcinogenesis 11, 1335-1342. (Pubitemid 20245706)
28. Huang, G. and Elferink, C.J. (2005). Multiple mechanisms are involved in Ah receptor-mediated cell cycle arrest. Mol. Pharmacol. 67, 88-96. (Pubitemid 40069969)
29. Ikuta, T. and Kawajiri, K. (2006). Zinc finger transcription factor Slug is a novel target of aryl hydrocarbon receptor. Exp. Cell Res. 312, 3585-3594. (Pubitemid 44470776)
30. Ikuta, T., Ohba, M., Zouboulis, C.C., Fujii-Kuriyama, Y., and Kawajiri, K.B. (2010). B lymphocyte-induced maturation protein 1 is a novel target gene of aryl hydrocarbon receptor. J. Dermatol. Sci. 58, 211-216.
31. Ju, Q., Fimmel, S., Hinz, N., Stahlmann. R., Xia, L., and Zouboulis, C.C. (2011). 2,3,7,8-Tetrachlorodibenzo-p-dioxin alters sebaceous gland cell differentiation in vitro. Exp. Dermatol. 20, 320-325.
32. Jux, B., Kadow, S., Luecke, S., Rannug, A., Krutmann, J., and Esser, C. (2011). The aryl hydrocarbon receptor mediated UVB radiation-induced skin tanning. J. Invest. Dermatol. 131, 203-210.
33. Kerkvliet, N.I. (2009). AHR-mediated immunomodulation: the role of altered gene transcription. Biochem. Pharmacol. 77, 746-760.
34. Kimmig, J. and Schulz, K.H. (1957). Berufliche Akne (sog. Chlorakne) durch chlorierte aromatische zyklischeÄther. Dermatologica 115, 540-546.
35. Kimura, A., Naka, T., Nohara, K. Fujii-Kuriyama, Y., and Kishimoto, T. (2008). Aryl hydrocarbon receptor regulates Stat1 activation and participates in the development of Th17 cells. Proc. Natl. Acad. Sci. USA 105, 9721-9726. (Pubitemid 352031367)
36. Kiss, E.A., Vonarbourg, C., Kopfmann, S., Hobeika, E., Finke, D., Esser, C., and Diefenbach A. (2011). Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles. Science 334, 1561-1565.
37. Köhle, C. and Bock, K.W. (2009). Coordinate regulation of human drug-metabolizing enzymes, and conjugate transporters by the Ah receptor, pregnane X receptor, and constitutive androstane receptor. Biochem. Pharmacol. 77, 689-699.
38. Köhle, C., Gschaidmeier, H., Lauth, D., Topell, S., Zitzer, H., and Bock, K.W. (1999). 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)- mediated membrane translocation of c-Src protein kinase in liver WB-F344 cells. Arch. Toxicol. 73, 152-158. (Pubitemid 29279501)
39. Köhle, C., Schwarz, M., and Bock, K.W. (2008). Promotion of hepatocarcinogenesis in humans and animal models. Arch. Toxicol. 82, 623-631.
40. Kolluri, S.K., Weiss, K., Koff, A., and Göttlicher, M. (1999). P27/KIP1 induction and inhibition of proliferation by the intracellular Ah receptor in developing thymus and hepatoma cells. Genes Dev. 13, 1742-1753. (Pubitemid 29325878)
41. Korn, T. (2010). How T cells take developmental decisions by using the aryl hydrocarbon receptor to sense the environment. Proc. Natl. Acad. Sci. USA 107, 20597-20598.
42. Lawrence, B.P. and Sherr, D.H. (2012). You AhR what you eat? Nat Immunol. 13, 117-119.
43. Lee, J.S., Cella, M., McDonald, K.G., Garlanda, C., Kennedy, G.D., Nukaya, M., Mantovani, A., Kopan, R., Bradfield, C.A., Newberry, R.D., et al. (2011). AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch. Nat. Immunol. 13, 144-151.
44. Li, Y., Innocentin, S., Withers, D.R., Roberts, N.A., Gallagher, A.R., Grigorieva, E.F., Wilhelm, C., and Veldhoen, M. (2011). Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation. Cell 147, 629-640.
45. Loertscher, J.A., Sattler, C.A., and Allen-Hoffmann, B.l. (2001). 2,3,7,8-Tetrachlorodibenzo- p -dioxin alters the differentiation pattern of human keratinocytes in organotypic culture. Toxicol. Appl. Pharmacol. 175, 121-129. (Pubitemid 32848503)
46. Luecke, S., Backlund, M., Jux, B., Esser, C., Krutmann, J., and Rannug, A. (2010). The aryl hydrocarbon receptor (AHR), a novel regulator of human melanogenesis. Pigment Cell Melanoma Res. 23, 828-833.
47. Ma, Q. and Whitlock, J.P. (1996). The aromatic hydrocarbon receptor modulates the hepa1c1c7 cell cycle and differentiated state independently of dioxin. Mol. Cell. Biol. 16, 2144-2150. (Pubitemid 26123735)
48. Machado, F.S., Johndrow, J.E., Esper, L., Dias, A., Bafica, A., Sherhan, C.N., and Aliberti, J. (2006). Anti-inflammatory actions of lipoxin A4 and aspirin-triggered lipoxin are SOCS-2 dependent. Nature 12, 330-334. (Pubitemid 43355082)
49. Marlowe, J.L., Fan, Y., Chang, X., Peng, L., Knutsen, E.S., Xia, Y., and Puga, A. (2008). The aryl hydrocarbon receptor binds to E2F1 and inhibits E2F1-induced apoptosis. Mol. Pharmacol. 19, 3263-3271.
50. McDaniell, R., Warthen, D.M., Sanchez-Lara, P.A., Pai, A., Krantz, I.D., Piccoli, D.A., and Spinner, N.B. (2006). Notch2 mutations cause Alagille syndrome, a heterogeneous disorder of the Notch signaling pathway. Am. J. Genet. 79, 169-173. (Pubitemid 43927389)
51. McIntosh, B.E., Hogenesch, J.B., and Bradfield, C.A. (2010). Mammalian Per-Arnt-Sim proteins in environmental adaptation. Ann. Rev. Physiol. 72, 625-645.
52. Mezrich, J.D., Fechner, J.H., Zhang, X., Johnson, B.P., Burlingham, W.J., and Bradfield, C.A. (2010). An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells. J. Immunol. 185, 3190-3198.
53. Mitchell, K.A. and Elferink, C.J. (2009). Timing is everything: Consequences of transient and sustained AhR activity. Biochem. Pharmacol. 77, 947-956.
54. Monteleone, I., Rizzo, A., Sarra, M., Sica, G., Sileri, P., Biancone, L., MacDonald, T.T., Pallone F., and Monteleone, G. (2011). Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract. Gastroenterol. 141, 237-248.
55. Moriguchi, T., Motohashi, H., Hosoya, T., Nakajima, O., Takahashi, S., Ohsako, S., Aoki, Y., Nishimura, N., Tohyama, C., Fujii- Kuriyama, Y., et al. (2003). Distinct response to dioxin in an arylhydrocarbon receptor (AHR)-humanized mouse. Proc. Natl. Acad. Sci. USA 100, 5652-5657. (Pubitemid 36576863)
56. Mü nzel, P., Bock-Hennig, B., Schieback, S., Gschaidmeier, H., Beck-Gschaidmeier, S., and Bock, K.W. (1996). Growth modulation of hepatocytes and rat liver epithelial cells (WB-F344) by 2,3,7,8-tetrachlorodibenzo- p -dioxin (TCDD). Carcinogenesis 17, 197-202. (Pubitemid 26091294)
57. Nebert, D.W., Dalton, T.P., Okey, A.B., and Gonzalez, F.J. (2004). Role of aryl hydrocarbon receptor-mediated induction of CYP1 enzymes in environmental toxicity and cancer. J. Biol. Chem. 279, 23847-23850. (Pubitemid 38725238)
58. Nguyen, L.P. and Bradfield, C.A. (2008). The search for endogenous activators of the aryl hydrocarbon receptor. Chem. Res. Toxicol. 21, 102-116. (Pubitemid 351219712)
59. Nguyen, L.P., Hsu, E.L., Chowdhury, G., Dostalek, M., Guengerich, F.P., and Bradfield, C.A. (2009). D-Amino acid oxidase generates agonists of the aryl hydrocarbon receptor from D-tryptophan. Chem. Res. Toxicol. 22, 1897-1904.
60. Okey, A.B. (2007). An aryl hydrocarbon receptor Odyssey to the shores of toxicology: The Deichmann lecture, International Congress of Toxicology-XI. Toxicol. Sci. 98, 5-38. (Pubitemid 47078751)
61. Opitz, C.A., Litzenburger, U.M., Sahm, F., Ott, M., Tritscher, I., Trump, S., Schumacher, T., Jestaedt, L., Schrenk, D., Weller, M., et al. (2011). An endogenous tumor-promoting ligand of the human aryl hydrocarbon receptor. Nature 478, 197-203.
62. Pantelejev, A.A. and Bickers, D.R. (2006). Dioxin-induced chloracne - reconstructing the cellular and molecular mechanisms of a classic environmental disease. Exp. Dermatol. 15, 705-730. (Pubitemid 44145241)
63. Park, K.T., Mitchell, K.A., Huang, G., and Elferink, C.J. (2005). The aryl hydrocarbon receptor predisposes hepatocytes to Fas-mediated apoptosis. Mol. Pharmacol. 67, 612-622. (Pubitemid 40365308)
64. Pitot, H.C., Goldsworthy, T.L., Campbell, H.A., and Poland, A. (1980). Quantitative evaluation of the promotion by 2,3,7,8-tetrachlorodibenzo- p -dioxin of hepatocarcinogenesis from diethylnitrosamine. Cancer Res. 40, 3616-3620. (Pubitemid 10003760)
65. Platzer, B., Richter, S., Kneidinger, D., Waltenberger, D., Woisetschläger, M., and Strobl, H. (2009). Aryl hydrocarbon receptor activation inhibits in vitro differentiation of human monocytes and Langerhans dendritic cells. J. Immunol. 183, 66-74.
66. Prendergast, G.C. (2008). Immune escape as a fundamental trait of cancer: focus on IDO. Oncogene 27, 3889-3900. (Pubitemid 351913639)
67. Puga, A., Barnes, S.J., Dalton, T.P., Chang, C.Y., Knutsen, E.S., and Maier, M.A. (2000). Aromatic hydrocarbon receptor interactions with the retinoblastoma protein potentiates repression of E2F-dependent transcription and cell cycle arrest. J. Biol. Chem. 275, 2943-2950. (Pubitemid 30082071)
68. Puga, A., Ma, C. and Marlowe, J.L. (2009). The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways. Biochem. Pharmacol. 77, 713-722.
69. Quintana, F.J., Basso, A.S., Iglesias, A.H., Korn, T., Farez, M.F., Betelli, S., Caccamo, M., Oukka, M., and Weiner, H.L. (2008). Control of Treg and Th17 cell differentiation by the aryl hydrocarbon receptor. Nature 453, 65-71. (Pubitemid 351630328)
70. Rannug, A., Rannug, U., Rosenkranz, H.S., Winqvist, L., Westerholm, R., Agurell, E., and Grafström, A.K. (1987). Certain photooxidized derivatives of tryptophan bind with very high affinity to the Ah receptor and are likely to be endogenous signal substances. J. Biol. Chem. 262, 15422-15427.
71. Sahlgren, C., Gustafsson, M.V., Jin, S., Poellinger, L., and Lendahl, U. (2008). Notch signaling mediates hypoxia-induced tumor cell migration and invasion. Proc. Natl. Acad. Sci. USA 105, 6392-6397. (Pubitemid 351758356)
72. Saurat, J.H., Kaya, G., Saxer-Sekulic, N., Pardo, B., Becker, M., Fontao, L., Mottu, F., Caraux, P., Pham, X.C., Barde, C., et al. (2012). The cutaneous lesions of dioxin exposure: lessons from the poisoning of Victor Yushchenko. Toxicol. Sci. 125, 310-317.
73. Schaldach, C.M., Riby, J., and Bjeldanes, L.F. (1999). Lipoxin A4: a new class of ligand for the Ah receptor. Biochemistry 38, 7594-7600.
74. Schrenk, D., Riebnicker, D., Till, M., Vetter, S., and Fiedler, H.P. (1997). Tryptanthrins: a novel class of agonists of the aryl hydrocarbon receptor. Biochem. Pharmacol. 54, 165-171. (Pubitemid 27353234)
75. Schroeder, J.C., DiNatale, B.C., Murray, I.A., Flaveny, C.A., Liu, Q., Laurenzana, E.M., Lin, J.M., Strom, S.C., Omiecinski, C.J., Amin, S., et al. (2010). The uremic toxin 3-indoxyl sulfate is a potent endogenous agonist for the human aryl hydrocarbon receptor. Biochemistry 49, 393-400.
76. Shimizu, Y., Nakatsuru, Y., Ichinose, M., Takahashi, Y., Kume, H., Mimura, J., Fujii-Kuriyama, Y., and Ishikawa, T. (2000). Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor. Proc. Natl. Acad. Sci. USA 97, 779-782. (Pubitemid 30070386)
77. Singh, K.P., Casado, F.L., Opanashuk, L.A., and Gasiewicz, T.A. (2009). The aryl hydrocarbon receptor has a normal function in the regulation of hematopoietic and other stem/progenitor cell populations. Biochem. Pharmacol. 77, 577-587.
78. Sneddon, J.B., Zhen, H.H., Montgomery, K., van de Rijn, M., Tward, A.D., West, R., Gladstone, H., Chang, H.Y., Morganroth, G.S., Oro, A.E., et al. (2006). Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer stromal cells and can promote tumor cell proliferation. Proc. Natl. Acad. Sci. USA 103, 14842-14847. (Pubitemid 44527816)
79. Spits, H. and Di Santo, J.P. (2011). The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nature Immunol. 12, 21-27.
80. Stevens, E.A., Mezrich, J.D., and Bradfield, C.A. (2009). The aryl hydrocarbon receptor: a perspective on potential roles in the immune system. Immunol. 127, 299-311.
81. Stinchcombe, S., Buchmann, A., Bock, K.W., and Schwarz, M. (1995). Inhibition of apoptosis during 2,3,7,8-tetrachlorodibenzo- p -dioxin-mediated tumour promotion in rat liver. Carcinogenesis 16, 1271-1275.
82. Suskind, R.R. (1985). Chloracne,'the hallmark of dioxin intoxication'. Scand. J. Work. Environ. Health 11, 165-171.
83. Sutter, T.R., Guzman, K., Dold, K.M., and Greenlee, W.F. (1991). Targets for dioxin: genes for plasminogen activator inhibitor-2 and interleukin-1. Science 254, 415-418. (Pubitemid 21917355)
84. Sutter, C.H., Bodreddigari, S., Campion, C., Wible, R.S., and Sutter, T.R. (2011). 2,3,7,8-Tetrachlorodibenzo- p -dioxin increases the expression of genes in the human epidermal differentiation complex and accelerates epidermal barrier function. Toxicol. Sci. 124, 128-137.
85. Tauchi, M., Hida, A., Negishi, T., Katsuoka, F., Noda, S., Mimura, J., Hosoya, T., Yanaka, A., Aburatani, H., Fujii-Kuriyama, Y., et al. (2005). Constitutive expression of aryl hydrocarbon receptor in keratinocytes causes inflammatory skin lesions. Mol. Cell. Biol. 25, 9360-9368. (Pubitemid 41507837)
86. Thiery, J.P. and Sleeman, J.P. (2006). Complex networks orchestrate epithelial-mesenchymal transitions. Nature Rev. Mol. Biol. 7, 131-142. (Pubitemid 43278296)
87. Thomsen, J.S., Kietz, S., Ström, A., and Gustafsson, J.A. (2004). Hes-1, a novel target gene for aryl hydrocarbon receptor. Mol. Pharmacol. 65, 165-171. (Pubitemid 38113897)
88. Tijet, N., Boutros, P.C., Moffat, I.D., Okey, A.B., Tuomisto, J., and Pohjanvirta, R. (2006). Aryl hydrocarbon receptor regulates distinct dioxin-dependent and dioxin-independent gene batteries. Mol. Pharmacol. 69, 140-153. (Pubitemid 43048901)
89. Trifari, S., Kaplan, C.D., Tran, E.H., Crellin, N.K., and Spits, H. (2009). Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from Th-17, Th1 and Th2 cells. Nature Immunol. 10, 864-871.
90. Vanden Heuvel, J.P., Clark, G.C., Kohn, M.C., Tritscher, A.M., Greenlee, W.F., Lucier G.W., and Bell D.A. (1994). Dioxinresponsive genes: examination of dose-response relationships using quantitative reverse transcriptase-polymerase chain reaction. Cancer Res. 54, 62-68. (Pubitemid 24042089)
91. Veldhoen, M., Hirota, K., Westendorf, A.M., Buer, J., Dumoutier, L., Renauld, J.C., and Stockinger, B. (2008). The aryl hydrocarbon receptor links Th17-cell-mediated autoimmunity to environmental toxins. Nature 453, 106-109. (Pubitemid 351630329)
92. Vogel, C.F.A., Sciullo, E., Li, W., Wong, P., Lazennec, G., and Matsumura, F. (2007a). RelB, a new partner of aryl hydrocarbon receptor-mediated transcription. Mol. Endocrinol. 21, 2941-2955. (Pubitemid 350223506)
93. Vogel, C.F.A., Li, W., Sciullo, E., Newman, J., Hammock, B., Reader, J.R., Tuscano, J., and Matsumura, F. (2007b). Pathogenesis of aryl hydrocarbon receptor-mediated development of lymphoma is associated with increased cyclooxygenase-2 expression. Am. J. Pathol. 171, 1538-1548. (Pubitemid 350158315)
94. Vogel, C.F.A., Goth, S.R., Dong, B., Pessah, I.N., and Matsumura, F. (2008). Aryl hydrocarbon receptor signaling mediates expression of indoleamine 2,3-dioxygenase. Biochem. Biophys. Res. Commun. 375, 331-335.
95. Walisser, J.A., Glover, E., Pande, K., Liss, A.L., and Bradfield, C.A. (2005). Aryl hydrocarbon receptor-dependent liver development and hepatotoxicity are mediated by different cell types. Proc. Natl. Acad. Sci. USA 102, 17858-17863. (Pubitemid 41803587)
96. Weiner, H.L., da Cunha, A.P., Quintana, F., and Wu, H. (2011). Oral tolerance. Immunol. Rev. 241, 241-259.
97. Weiss, C., Faust, D., Schreck, I., Ruff, A., Farwerck, T., Melenberg, A., Schneider, S., Oesch-Bartlomowicz, B., Zatloukalova, J., Vondracek, J., et al. (2008). TCDD deregulates contact inhibition in rat liver oval cells via Ah receptor, JunD and cyclin A. Oncogene 27, 2198-2207. (Pubitemid 351483381)
98. Whitlock, J.P. (1999). Induction of cytochrome P4501A1. Ann. Rev. Pharmacol. Toxicol. 39, 103-125.
99. Wincent, E., Amini, N., Luecke, S., Glatt, H., Bergman, J., Crescenzi, C., Rannug, A., and Rannug, U. (2009). The suggested physiologic aryl hydrocarbon receptor activator and cytochrome P4501 substrate 6-folmylindolo[3,2-b]carbazole is present in humans. J. Biol. Chem. 284, 2690-2696.
100. Wincent, E., Bengtsson, J., Bardbori, A.M., Alsberg, T., Luecke, S., Rannug, U., and Rannug, A. (2012). Inhibition of cytochrome P4501-dependent clearance of the endogenous agonist FICZ as a mechanism for activation of the aryl hydrocarbon receptor. Proc. Natl. Acad. Sci. USA 109, 4479-4484.